Ribavirin for patients with Crimean-Congo haemorrhagic fever: a systematic review and meta-analysis

Creative Commons License

Ascioglu S., Leblebicioglu H., Vahaboglu H., Chan K. A.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, cilt.66, sa.6, ss.1215-1222, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Derleme
  • Cilt numarası: 66 Sayı: 6
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1093/jac/dkr136
  • Dergi Adı: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1215-1222
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background: Crimean-Congo haemorrhagic fever (CCHF) is a potentially fatal tick-borne infection. The virus is widely distributed around the world and reports of sporadic cases and outbreaks have recently increased significantly. Some authors have proposed that ribavirin improves survival in CCHF and this view appears to be widely accepted.